Loading clinical trials...
Loading clinical trials...
Frequency of Fabry Disease in Portuguese Patients With Idiopathic Cardiomyopathies
Conditions
Interventions
Alfa-galactosidase activity and genetic testing for Fabry diagnosis
Locations
11
Portugal
Centro Hospitalar Universitário de Coimbra
Coimbra, Portugal
Hospital da Luz, Lisboa
Lisbon, Portugal
Centro Hospitalar Universitário Lisboa Norte, EPE., Hospital de Santa Maria
Lisbon, Portugal
Hospital Pedro Hispano (Unidade Local de Saúde Matosinhos)
Matosinhos Municipality, Portugal
Centro Hospitalar do Tâmega e Sousa, Hospital Padre Américo
Penafiel, Portugal
Centro Hospitalar Universitário de Santo António
Porto, Portugal
Start Date
April 15, 2022
Primary Completion Date
January 1, 2025
Completion Date
April 15, 2025
Last Updated
October 2, 2025
NCT06941025
NCT07382128
NCT05923788
NCT05473637
NCT07277361
NCT04252066
Lead Sponsor
Universidade do Porto
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions